Campinas, Brazil

Marcelo Nicolas Muscarà

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Genetic Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marcelo Nicolas Muscarà. Retrieved from https://idiyas.com/inventor/marcelo-nicolas-muscarà

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Marcelo Nicolas Muscarà

Introduction

Marcelo Nicolas Muscarà is an accomplished inventor based in Campinas, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory conditions. His innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

One of Muscarà's notable patents is titled "Budesonide 21-phosphate salts and pharmaceutical compositions containing the same." This invention relates to salts of budesonide 21-phosphate combined with β2 adrenergic agonists, specifically formoterol. The pharmaceutical compositions developed from this patent are designed for the treatment of respiratory inflammatory pathologies, obstructive pathologies, and allergen-induced airway dysfunctions. Additionally, the patent outlines the process for preparing these salts, showcasing Muscarà's innovative approach to pharmaceutical development.

Career Highlights

Marcelo Muscarà is associated with Genetic S.p.a., a company that focuses on advancing pharmaceutical solutions. His work at Genetic S.p.a. has allowed him to collaborate with other talented professionals in the field, contributing to the development of effective treatments for respiratory ailments.

Collaborations

Muscarà has worked alongside notable colleagues such as Giuseppe Caliendo and Giuseppe Cirino. Their combined expertise has fostered a collaborative environment that enhances the innovation process within the company.

Conclusion

Marcelo Nicolas Muscarà's contributions to pharmaceutical innovation, particularly through his patent on budesonide 21-phosphate salts, highlight his commitment to improving respiratory health. His work continues to impact the field positively, paving the way for future advancements in treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…